The PT-141 peptide is FDA approved as the injectable brand-name medication Vyleesi (bremelanotide), which is indicated for premenopausal women who have hypoactive sexual desire disorder not caused by a medical or mental health condition, relationship problems, or medication side effects
High-ROS environments can degrade the peptide, which is relevant in oxidative stress model experiments
Glutathione IV therapy is one of several IV-based treatments we provide at Astra Medicare, alongside vitamin C IV therapy, IV vitamin cocktails, and M.I.C
Reference: Enhanced HGF with increased receptor affinity and nitration-dysfunction resistance through interaction with lipoic acid trisulfide by Kahona Zushi, Miyumi Seki, Ryota Mizuochi, Kazuki Shitamitsu, Alaa Elgaabari, Sakiho Tanaka, Junri Miyamoto, Kaoru Mizoguchi, Reina Fujimaru, Jiaxi Han, Takashi Nakashima, Shoko Sawano, Wataru Mizunoya, Takahiro Maeno, Issei Yokoyama, Takahiro Suzuki, Judy E
Wang Y, Wu W, Mao D, Teh C, Wang B, Liu B
They are not advised for people with a personal or family history of medullary thyroid cancer